BBMG (02009) Income Statement & Earnings

0.750
-0.010-1.32%

Market Closed May 14 16:07 CST

8.01BMarket Cap-4.87P/E (TTM)

BBMG (02009) Income Statement

All

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q9)Sep 30, 2025

(Q6)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

Turnover

-9.19%15.32B

-17.70%91.11B

-9.80%69.49B

0.01%45.57B

31.42%16.87B

2.55%110.71B

6.12%77.04B

-7.27%45.56B

-45.34%12.83B

4.99%107.96B

Operating income

-9.19%15.32B

-17.70%91.11B

-9.80%69.49B

0.01%45.57B

31.42%16.87B

2.55%110.71B

6.12%77.04B

-7.27%45.56B

-45.34%12.83B

4.99%107.96B

Operating expenses

8.60%-14.58B

19.13%-80.17B

9.68%-62.61B

0.91%-40.61B

-29.42%-15.95B

-3.29%-99.13B

-7.06%-69.31B

6.06%-40.98B

42.17%-12.33B

-9.72%-95.97B

Gross profit

-19.42%735.55M

-5.49%10.94B

-10.88%6.88B

8.20%4.96B

80.11%912.77M

-3.39%11.58B

-1.64%7.72B

-16.91%4.58B

-76.61%506.79M

-21.96%11.98B

Selling expenses

5.18%-527.2M

-0.02%-2.33B

-4.28%-1.77B

-1.88%-1.14B

-8.01%-555.99M

2.70%-2.33B

7.26%-1.7B

2.22%-1.12B

11.69%-514.76M

-1.18%-2.4B

Administrative expenses

5.15%-1.61B

0.55%-6.61B

-2.59%-4.84B

-1.32%-3.42B

-6.83%-1.69B

-1.26%-6.65B

-8.55%-4.72B

-3.41%-3.38B

-7.11%-1.59B

5.64%-6.57B

Research and development expenses

-0.07%-150.56M

-11.43%-742.01M

-0.72%-559.5M

-18.38%-356.67M

-13.04%-150.45M

-25.60%-665.89M

-16.71%-555.5M

-15.44%-301.29M

-27.56%-133.09M

-29.27%-530.17M

Profit from asset sales

29.55%26.22M

66.22%1.99B

76.41%1.79B

-79.50%204.98M

-55.79%20.24M

4.37%1.2B

55.96%1.01B

61.33%999.79M

-73.46%45.78M

-12.09%1.15B

Revaluation surplus

-55.50%6.31M

-45.32%403.79M

-18.73%182.6M

-12.00%184.85M

-40.74%14.19M

-36.70%738.5M

-33.64%224.69M

-37.61%210.06M

82.80%23.95M

100.11%1.17B

-Changes in the fair value of other assets

-55.50%6.31M

-45.32%403.79M

-18.73%182.6M

-12.00%184.85M

-40.74%14.19M

-36.70%738.5M

-33.64%224.69M

-37.61%210.06M

82.80%23.95M

100.11%1.17B

Impairment and provision

50.04%81.67M

-36.50%-1.37B

-131.80%-89.69M

70.77%-113.52M

41.84%54.43M

49.25%-1.01B

653.16%282.02M

-158.69%-388.41M

284.18%38.38M

-54.74%-1.98B

-Other impairment is provision

50.04%81.67M

-36.50%-1.37B

-131.80%-89.69M

70.77%-113.52M

41.84%54.43M

49.25%-1.01B

653.16%282.02M

-158.69%-388.41M

284.18%38.38M

-54.74%-1.98B

Special items of operating profit

-83.74%64.93M

-20.80%1.32B

9.93%690.12M

39.72%558.84M

-1.70%399.22M

136.47%1.67B

13.72%627.78M

10.10%399.96M

338.88%406.14M

-18.45%705.26M

Operating profit

-25.36%-1.66B

-28.54%2.27B

-40.83%1.24B

-95.21%20.82M

-7.38%-1.32B

30.76%3.18B

0.05%2.1B

-73.62%434.72M

-2,433.69%-1.23B

-58.19%2.43B

Financing income

47.89%66.84M

12.19%235.82M

-54.98%171.34M

6.34%91.29M

2.97%45.2M

-21.46%210.2M

-17.78%380.57M

-39.86%85.85M

-54.60%43.89M

17.37%267.64M

Financing cost

12.66%-625.95M

4.42%-2.81B

9.78%-2.37B

7.94%-1.53B

11.81%-716.66M

-22.20%-2.94B

-8.05%-2.63B

-24.45%-1.66B

-6.23%-812.65M

45.89%-2.41B

Special items of earning before tax

-27.19%33.71M

430.09%389.6M

-25.22%146.28M

34.34%106.55M

74.50%46.29M

-48.97%73.5M

140.57%195.61M

9.25%79.32M

44.81%26.53M

-26.52%144.02M

Earning before tax

-12.38%-2.2B

-92.91%32.35M

-7,631.43%-835.98M

-24.28%-1.33B

1.38%-1.96B

51.84%456.1M

-89.32%11.1M

-351.47%-1.07B

-173.87%-1.99B

-90.97%300.39M

After-tax profit from continuing operations

-4.34%-2.22B

1.80%-1.51B

-125.26%-1.95B

-9.11%-1.91B

-2.28%-2.13B

-19.17%-1.53B

-106.65%-865.62M

-12,035.15%-1.75B

-146.74%-2.08B

-173.99%-1.29B

Earning after tax

-4.34%-2.22B

1.80%-1.51B

-125.26%-1.95B

-9.11%-1.91B

-2.28%-2.13B

-19.17%-1.53B

-106.65%-865.62M

-12,035.15%-1.75B

-146.74%-2.08B

-173.99%-1.29B

Minority profit

39.25%-542.67M

49.22%-497.17M

-22.33%-524.87M

56.17%-413.28M

-15.73%-893.21M

25.42%-979.05M

0.10%-429.07M

-138.46%-942.87M

-50.89%-771.81M

-348.98%-1.31B

Profit attributable to shareholders

-35.88%-1.68B

-81.83%-1.01B

-226.44%-1.43B

-85.40%-1.5B

5.65%-1.23B

-2,297.55%-555.16M

-4,212.65%-436.54M

-296.72%-806.67M

-294.57%-1.31B

-97.92%25.26M

Basic earnings per share

-33.33%-0.16

-26.67%-0.19

-224.39%-0.133

-58.33%-0.19

0.00%-0.12

-87.50%-0.15

-4,200.00%-0.041

-4,900.00%-0.12

-300.00%-0.12

-366.67%-0.08

Diluted earnings per share

-33.33%-0.16

-26.67%-0.19

-224.39%-0.133

-58.33%-0.19

0.00%-0.12

-87.50%-0.15

-4,200.00%-0.041

-4,900.00%-0.12

-300.00%-0.12

-366.67%-0.08

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified Opinion

Auditor

Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)

Ernst & Young Huaming Accounting Firm (Special General Partnership)

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q9)Sep 30, 2025	(Q6)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023
Turnover	-9.19%15.32B	-17.70%91.11B	-9.80%69.49B	0.01%45.57B	31.42%16.87B	2.55%110.71B	6.12%77.04B	-7.27%45.56B	-45.34%12.83B	4.99%107.96B
Operating income	-9.19%15.32B	-17.70%91.11B	-9.80%69.49B	0.01%45.57B	31.42%16.87B	2.55%110.71B	6.12%77.04B	-7.27%45.56B	-45.34%12.83B	4.99%107.96B
Operating expenses	8.60%-14.58B	19.13%-80.17B	9.68%-62.61B	0.91%-40.61B	-29.42%-15.95B	-3.29%-99.13B	-7.06%-69.31B	6.06%-40.98B	42.17%-12.33B	-9.72%-95.97B
Gross profit	-19.42%735.55M	-5.49%10.94B	-10.88%6.88B	8.20%4.96B	80.11%912.77M	-3.39%11.58B	-1.64%7.72B	-16.91%4.58B	-76.61%506.79M	-21.96%11.98B
Selling expenses	5.18%-527.2M	-0.02%-2.33B	-4.28%-1.77B	-1.88%-1.14B	-8.01%-555.99M	2.70%-2.33B	7.26%-1.7B	2.22%-1.12B	11.69%-514.76M	-1.18%-2.4B
Administrative expenses	5.15%-1.61B	0.55%-6.61B	-2.59%-4.84B	-1.32%-3.42B	-6.83%-1.69B	-1.26%-6.65B	-8.55%-4.72B	-3.41%-3.38B	-7.11%-1.59B	5.64%-6.57B
Research and development expenses	-0.07%-150.56M	-11.43%-742.01M	-0.72%-559.5M	-18.38%-356.67M	-13.04%-150.45M	-25.60%-665.89M	-16.71%-555.5M	-15.44%-301.29M	-27.56%-133.09M	-29.27%-530.17M
Profit from asset sales	29.55%26.22M	66.22%1.99B	76.41%1.79B	-79.50%204.98M	-55.79%20.24M	4.37%1.2B	55.96%1.01B	61.33%999.79M	-73.46%45.78M	-12.09%1.15B
Revaluation surplus	-55.50%6.31M	-45.32%403.79M	-18.73%182.6M	-12.00%184.85M	-40.74%14.19M	-36.70%738.5M	-33.64%224.69M	-37.61%210.06M	82.80%23.95M	100.11%1.17B
-Changes in the fair value of other assets	-55.50%6.31M	-45.32%403.79M	-18.73%182.6M	-12.00%184.85M	-40.74%14.19M	-36.70%738.5M	-33.64%224.69M	-37.61%210.06M	82.80%23.95M	100.11%1.17B
Impairment and provision	50.04%81.67M	-36.50%-1.37B	-131.80%-89.69M	70.77%-113.52M	41.84%54.43M	49.25%-1.01B	653.16%282.02M	-158.69%-388.41M	284.18%38.38M	-54.74%-1.98B
-Other impairment is provision	50.04%81.67M	-36.50%-1.37B	-131.80%-89.69M	70.77%-113.52M	41.84%54.43M	49.25%-1.01B	653.16%282.02M	-158.69%-388.41M	284.18%38.38M	-54.74%-1.98B
Special items of operating profit	-83.74%64.93M	-20.80%1.32B	9.93%690.12M	39.72%558.84M	-1.70%399.22M	136.47%1.67B	13.72%627.78M	10.10%399.96M	338.88%406.14M	-18.45%705.26M
Operating profit	-25.36%-1.66B	-28.54%2.27B	-40.83%1.24B	-95.21%20.82M	-7.38%-1.32B	30.76%3.18B	0.05%2.1B	-73.62%434.72M	-2,433.69%-1.23B	-58.19%2.43B
Financing income	47.89%66.84M	12.19%235.82M	-54.98%171.34M	6.34%91.29M	2.97%45.2M	-21.46%210.2M	-17.78%380.57M	-39.86%85.85M	-54.60%43.89M	17.37%267.64M
Financing cost	12.66%-625.95M	4.42%-2.81B	9.78%-2.37B	7.94%-1.53B	11.81%-716.66M	-22.20%-2.94B	-8.05%-2.63B	-24.45%-1.66B	-6.23%-812.65M	45.89%-2.41B
Special items of earning before tax	-27.19%33.71M	430.09%389.6M	-25.22%146.28M	34.34%106.55M	74.50%46.29M	-48.97%73.5M	140.57%195.61M	9.25%79.32M	44.81%26.53M	-26.52%144.02M
Earning before tax	-12.38%-2.2B	-92.91%32.35M	-7,631.43%-835.98M	-24.28%-1.33B	1.38%-1.96B	51.84%456.1M	-89.32%11.1M	-351.47%-1.07B	-173.87%-1.99B	-90.97%300.39M
After-tax profit from continuing operations	-4.34%-2.22B	1.80%-1.51B	-125.26%-1.95B	-9.11%-1.91B	-2.28%-2.13B	-19.17%-1.53B	-106.65%-865.62M	-12,035.15%-1.75B	-146.74%-2.08B	-173.99%-1.29B
Earning after tax	-4.34%-2.22B	1.80%-1.51B	-125.26%-1.95B	-9.11%-1.91B	-2.28%-2.13B	-19.17%-1.53B	-106.65%-865.62M	-12,035.15%-1.75B	-146.74%-2.08B	-173.99%-1.29B
Minority profit	39.25%-542.67M	49.22%-497.17M	-22.33%-524.87M	56.17%-413.28M	-15.73%-893.21M	25.42%-979.05M	0.10%-429.07M	-138.46%-942.87M	-50.89%-771.81M	-348.98%-1.31B
Profit attributable to shareholders	-35.88%-1.68B	-81.83%-1.01B	-226.44%-1.43B	-85.40%-1.5B	5.65%-1.23B	-2,297.55%-555.16M	-4,212.65%-436.54M	-296.72%-806.67M	-294.57%-1.31B	-97.92%25.26M
Basic earnings per share	-33.33%-0.16	-26.67%-0.19	-224.39%-0.133	-58.33%-0.19	0.00%-0.12	-87.50%-0.15	-4,200.00%-0.041	-4,900.00%-0.12	-300.00%-0.12	-366.67%-0.08
Diluted earnings per share	-33.33%-0.16	-26.67%-0.19	-224.39%-0.133	-58.33%-0.19	0.00%-0.12	-87.50%-0.15	-4,200.00%-0.041	-4,900.00%-0.12	-300.00%-0.12	-366.67%-0.08
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion
Auditor	--	Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)	--	--	--	Ernst & Young Huaming Accounting Firm (Special General Partnership)	--	--	--	Ernst & Young Huaming Accounting Firm (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"